CA2588195C - Novel antiviral and immune stimulant pharmaceutical composition - Google Patents

Novel antiviral and immune stimulant pharmaceutical composition Download PDF

Info

Publication number
CA2588195C
CA2588195C CA2588195A CA2588195A CA2588195C CA 2588195 C CA2588195 C CA 2588195C CA 2588195 A CA2588195 A CA 2588195A CA 2588195 A CA2588195 A CA 2588195A CA 2588195 C CA2588195 C CA 2588195C
Authority
CA
Canada
Prior art keywords
pharmaceutical composition
novel antiviral
acid ester
immune stimulant
mass
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA2588195A
Other languages
English (en)
French (fr)
Other versions
CA2588195A1 (en
Inventor
Jenoe Szilbereky
Andrea Jednakovits
Ernone Koltai
Gyula Orban
Katalin Biro
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SINNEX MUESZAKI FEJLESZTOE ES TANACSADO KFT
Original Assignee
SINNEX MUESZAKI FEJLESZTOE ES TANACSADO KFT
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SINNEX MUESZAKI FEJLESZTOE ES TANACSADO KFT filed Critical SINNEX MUESZAKI FEJLESZTOE ES TANACSADO KFT
Publication of CA2588195A1 publication Critical patent/CA2588195A1/en
Application granted granted Critical
Publication of CA2588195C publication Critical patent/CA2588195C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/04Sulfur, selenium or tellurium; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/30Zinc; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA2588195A 2004-12-03 2005-11-15 Novel antiviral and immune stimulant pharmaceutical composition Expired - Fee Related CA2588195C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
HU0402490A HU227588B1 (hu) 2004-12-03 2004-12-03 Többszörösen telítetlen zsírsavak észtereit tartalmazó vírusellenes és immunstimuláns gyógyászati készítmény
HUP0402490 2004-12-03
PCT/HU2005/000122 WO2006059169A2 (en) 2004-12-03 2005-11-15 Antiviral and immunostimulating marine fish oil composition

Publications (2)

Publication Number Publication Date
CA2588195A1 CA2588195A1 (en) 2006-06-08
CA2588195C true CA2588195C (en) 2014-12-23

Family

ID=89985663

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2588195A Expired - Fee Related CA2588195C (en) 2004-12-03 2005-11-15 Novel antiviral and immune stimulant pharmaceutical composition

Country Status (13)

Country Link
US (1) US9381213B2 (https=)
EP (1) EP1830861B1 (https=)
JP (1) JP4976307B2 (https=)
KR (1) KR101263963B1 (https=)
CN (1) CN101068540B (https=)
AT (1) ATE429236T1 (https=)
CA (1) CA2588195C (https=)
DE (1) DE602005014142D1 (https=)
DK (1) DK1830861T3 (https=)
ES (1) ES2326091T3 (https=)
HU (1) HU227588B1 (https=)
PL (1) PL1830861T3 (https=)
WO (1) WO2006059169A2 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1800675T3 (da) 2005-12-23 2011-09-05 Nutricia Nv Sammensætninger omfattende polyumættede fedtsyrer, proteiner og mangan og/eller molybdæn og nucleosider/nucleotider til behandling af demens
SG10201605794PA (en) * 2009-04-29 2016-09-29 Amarin Pharmaceuticals Ie Ltd Stable Pharmaceutical Composition And Methods Of Using Same
JP5710150B2 (ja) * 2010-04-08 2015-04-30 持田製薬株式会社 潜伏性感染疾患の再発抑制剤
JP2012149000A (ja) * 2011-01-18 2012-08-09 Junsei Educational Institution 免疫賦活剤ならびにこれを含む食品および医薬組成物
EP3248467A1 (de) * 2016-05-25 2017-11-29 Evonik Technochemie GmbH Verfahren zur herstellung einer zusammensetzung enthaltend omega-3-fettsäure-l-lysin-salze
US20220175850A1 (en) * 2019-04-01 2022-06-09 Houn Simon Hsia Compositions and methods for cancer therapy
AU2021324673B2 (en) * 2020-08-10 2025-07-24 Houn Simon Hsia Compositions and methods for treating viral infection

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU209973B (en) * 1988-03-09 1995-01-30 Biorex Kutato Fejlesztoe Kft Process for production of antiviral and immunstimular pharmaceutical composition
HU199775B (en) * 1988-03-09 1990-03-28 Nagy Peter Literati Process for production of formed by fatty acids salts of amin acids and medical compositions containing them
HU210122B (en) * 1988-03-23 1995-02-28 Biorex Kutato Fejlesztoe Kft Process for production of composition against thromboembolytic conditions of circulating system and heart
IT1264987B1 (it) * 1993-12-14 1996-10-17 Prospa Bv Sali di un acido grasso poliinsaturo e formulazioni farmaceutiche che li contengono
IT1274734B (it) * 1994-08-25 1997-07-24 Prospa Bv Composizioni farmaceutiche contenenti acidi grassi poliinsaturi, loro esteri o sali, unitamente a vitamine o provitamine antiossidanti
EP0891771A1 (en) * 1997-07-08 1999-01-20 Health Now, Inc. Compositions comprising lysine and ascorbate compounds for the treatment and prevention of cardiovascular diseases
WO1999029316A1 (en) * 1997-12-10 1999-06-17 Severson, Mary, L. Pharmaceutical compositions containing an omega-3 fatty acid oil
AT412758B (de) * 2000-06-05 2005-07-25 Vis Vitalis Lizenz & Handels Verwendung einer selenithältigen lösung zur behandlung viraler erkrankungen
ATE555782T1 (de) * 2002-03-08 2012-05-15 Philera New Zealand Ltd Prävention und/oder behandlung von kardiovaskulären erkrankungen und/oder damit zusammenhängender herzinsuffizienz

Also Published As

Publication number Publication date
DK1830861T3 (da) 2009-07-27
JP4976307B2 (ja) 2012-07-18
PL1830861T3 (pl) 2009-09-30
KR101263963B1 (ko) 2013-05-13
HU0402490D0 (en) 2005-02-28
KR20070086689A (ko) 2007-08-27
EP1830861A2 (en) 2007-09-12
EP1830861B1 (en) 2009-04-22
CN101068540A (zh) 2007-11-07
ATE429236T1 (de) 2009-05-15
WO2006059169A3 (en) 2007-02-22
ES2326091T3 (es) 2009-09-30
US9381213B2 (en) 2016-07-05
HU227588B1 (hu) 2011-09-28
DE602005014142D1 (de) 2009-06-04
JP2008521877A (ja) 2008-06-26
HUP0402490A2 (en) 2009-04-28
CN101068540B (zh) 2013-01-09
CA2588195A1 (en) 2006-06-08
US20080131519A1 (en) 2008-06-05
WO2006059169A2 (en) 2006-06-08

Similar Documents

Publication Publication Date Title
ATE332639T1 (de) Herbizidzusammensetzung,umfassend herbizide verbindung in säureform und ansäuerndes mittel, applizierverfahren und herstellungsverfahren davon
NZ516101A (en) Pharmaceutical and nutritional compositions containing essential fatty acids and homocysteine-lowering agents
DE69829853D1 (de) Nahrungszusammensetzungen enthaltend methionin
UA93879C2 (ru) Гербицидная композиция c одной жидкой фазой
CA2481848A1 (en) Active ingredient particles carrying clopidogrel or a salt thereof, their use and method of preparation
EA200700566A1 (ru) Фармацевтические композиции, включающие леветирацетам, и способы их получения
MX2007001553A (es) Nuevas composiciones farmaceuticas de estatina y metodos de tratamiento relacionados.
TW200531696A (en) Pharmaceutical formulations of bisphosphonates
TNSN05189A1 (en) Medium-chain length fatty acids, glycerides and analogues as stimulators of erythropoiesis
TW200633716A (en) Compositions and methods for stabilizing active pharmaceutical ingredients
MX2009005299A (es) Maiz extraido con solvente.
BRPI0508579A (pt) composto, composição farmacêutica, e, uso de um composto
UA86937C2 (ru) Композиция, которая содержит лактат и калий, и ее применение
FR2743075B1 (fr) Procede de preparation de substances actives a partir de la nacre, produits obtenus, utiles notamment comme medicaments
CA2588195C (en) Novel antiviral and immune stimulant pharmaceutical composition
MXPA02012889A (es) Esteres de acidos 4-alcoxi-ciclohexano-1-amino-carboxilicos y procedimiento para su obtencion.
AR025320A1 (es) Composicion liquida para mejorar el pan
AR046940A1 (es) Composiciones comestibles adaptadas para ser usadas por un animal de compania
BRPI0417093A (pt) composição para consumo animal, método para aumentar a palatabilidade de uma composição de ração, método para aumentar a ingestão de uma ração por um animal, processo para a preparação de uma composição para consumo animal, e, refeição e brinquedo para animal
Hodgson et al. Substitution of choline by related compounds and further studies on amino acid requirements in nutrition of Phormia regina (Meig.)
CY1112057T1 (el) Θεραπευτικος παραγων για διαταραχη επαρκειας τροφης στο στομαχι
TN2010000058A1 (fr) Composition therapeutique aromatisee a base d'argile
DE602004017514D1 (de) Stabile orale pharmazeutische zusammensetzungen von buprenorphin und salz davon
WO2008078453A1 (ja) 血小板産生促進因子及びその利用
PL1970372T3 (pl) Sole kwasu 9-oksoakrydyno-10-octowego z 1-alkiloamino-1-deoksypoliolami

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20221115